Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Westwood KS,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for
Metastatic Salivary Gland Carcinoma,
Location: Oklahoma City OK, Lawton OK, Salina KS, Hays KS,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase 2, Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Oklahoma City OK, Dallas TX, Austin TX, Houston TX,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase 3, Recruiting

Ketamine for Post-operative Analgesia in Hemorrhoidectomy

for
Hemorrhoids
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT04248205

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Oklahoma City OK, Fort Worth TX, Dallas TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Oklahoma City OK, McKinney TX, Dallas TX, Birmingham AL,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 40+

Code: NCT05975983

Phase 2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Oklahoma City OK, Overland Park KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

EffectiveNess and SAfety of Small ANeurysm COiling Trial

for
Aneurysm
Location: Oklahoma City OK, Englewood CO, Louisville KY,
Sponsor: University of Virginia

Sex: All

Age: 18 - 70+

Code: NCT02167997

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Oklahoma City OK, Richardson TX, Fort Smith AR,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase 3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Oklahoma City OK, Overland Park KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase 2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Oklahoma City OK, Dallas TX, Overland Park KS,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Oklahoma City OK, Fort Worth TX, Dallas TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Oklahoma City OK, Lawton OK, Salina KS, Amarillo TX,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Oklahoma City OK, Fort Worth TX, Dallas TX, Lubbock TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

for
Septic Shock
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT03992378

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Oklahoma City OK, Fort Worth TX, Denver CO, Peoria IL,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701656

Phase 2, Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

for
Advanced Malignant Solid Neoplasm,
Location: Oklahoma City OK, Gainesville FL, New Haven CT
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05053971

Phase 1, Phase 2, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Oklahoma City OK, Dallas TX, Little Rock AR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Substance Use Treatment and Access to Resources (STARS) Project

for
Substance Use Disorders, Pregnancy Related, Child Neglect
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 0 - 55

Code: NCT04459000

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Oklahoma City OK, Tulsa OK, Wichita KS, Dallas TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting